Cargando…
Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma
BACKGROUND: We previously reported that two differentially methylated region (DMR) networks identified by DMR and co-methylation analyses are strongly correlated with the fibrosis stages of nonalcoholic fatty liver disease (NAFLD). In the current study, we examined these DMR networks in viral hepati...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164838/ https://www.ncbi.nlm.nih.gov/pubmed/35655171 http://dx.doi.org/10.1186/s12876-022-02360-4 |
_version_ | 1784720237984219136 |
---|---|
author | Kurokawa, Suguru Yoneda, Masato Ogawa, Yuji Honda, Yasushi Kessoku, Takaomi Imajo, Kento Saito, Satoru Nakajima, Atsushi Hotta, Kikuko |
author_facet | Kurokawa, Suguru Yoneda, Masato Ogawa, Yuji Honda, Yasushi Kessoku, Takaomi Imajo, Kento Saito, Satoru Nakajima, Atsushi Hotta, Kikuko |
author_sort | Kurokawa, Suguru |
collection | PubMed |
description | BACKGROUND: We previously reported that two differentially methylated region (DMR) networks identified by DMR and co-methylation analyses are strongly correlated with the fibrosis stages of nonalcoholic fatty liver disease (NAFLD). In the current study, we examined these DMR networks in viral hepatitis and hepatocellular carcinoma (HCC). METHODS: We performed co-methylation analysis of DMRs using a normal dataset (GSE48325), two NAFLD datasets (JGAS000059 and GSE31803), and two HCC datasets (GSE89852 and GSE56588). The dataset GSE60753 was used for validation. RESULTS: One DMR network was clearly observed in viral hepatitis and two HCC populations. Methylation levels of genes in this network were higher in viral hepatitis and cirrhosis, and lower in HCC. Fatty acid binding protein 1 (FABP1), serum/glucocorticoid regulated kinase 2 (SGK2), and hepatocyte nuclear factor 4 α (HNF4A) were potential hub genes in this network. Increased methylation levels of the FABP1 gene may be correlated with reduced protection of hepatocytes from oxidative metabolites in NAFLD and viral hepatitis. The decreased methylation levels of SGK2 may facilitate the growth and proliferation of HCC cells. Decreased methylation levels of HNF4A in HCC may be associated with tumorigenesis. The other DMR network was observed in NAFLD, but not in viral hepatitis or HCC. This second network included genes involved in transcriptional regulation, cytoskeleton organization, and cellular proliferation, which are specifically related to fibrosis and/or tumorigenesis in NAFLD. CONCLUSIONS: Our results suggest that one DMR network was associated with fibrosis and tumorigenesis in both NAFLD and viral hepatitis, while the other network was specifically associated with NAFLD progression. Furthermore, FABP1, SGK2, and HNF4A are potential candidate targets for the prevention and treatment of HCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02360-4. |
format | Online Article Text |
id | pubmed-9164838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91648382022-06-05 Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma Kurokawa, Suguru Yoneda, Masato Ogawa, Yuji Honda, Yasushi Kessoku, Takaomi Imajo, Kento Saito, Satoru Nakajima, Atsushi Hotta, Kikuko BMC Gastroenterol Research BACKGROUND: We previously reported that two differentially methylated region (DMR) networks identified by DMR and co-methylation analyses are strongly correlated with the fibrosis stages of nonalcoholic fatty liver disease (NAFLD). In the current study, we examined these DMR networks in viral hepatitis and hepatocellular carcinoma (HCC). METHODS: We performed co-methylation analysis of DMRs using a normal dataset (GSE48325), two NAFLD datasets (JGAS000059 and GSE31803), and two HCC datasets (GSE89852 and GSE56588). The dataset GSE60753 was used for validation. RESULTS: One DMR network was clearly observed in viral hepatitis and two HCC populations. Methylation levels of genes in this network were higher in viral hepatitis and cirrhosis, and lower in HCC. Fatty acid binding protein 1 (FABP1), serum/glucocorticoid regulated kinase 2 (SGK2), and hepatocyte nuclear factor 4 α (HNF4A) were potential hub genes in this network. Increased methylation levels of the FABP1 gene may be correlated with reduced protection of hepatocytes from oxidative metabolites in NAFLD and viral hepatitis. The decreased methylation levels of SGK2 may facilitate the growth and proliferation of HCC cells. Decreased methylation levels of HNF4A in HCC may be associated with tumorigenesis. The other DMR network was observed in NAFLD, but not in viral hepatitis or HCC. This second network included genes involved in transcriptional regulation, cytoskeleton organization, and cellular proliferation, which are specifically related to fibrosis and/or tumorigenesis in NAFLD. CONCLUSIONS: Our results suggest that one DMR network was associated with fibrosis and tumorigenesis in both NAFLD and viral hepatitis, while the other network was specifically associated with NAFLD progression. Furthermore, FABP1, SGK2, and HNF4A are potential candidate targets for the prevention and treatment of HCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02360-4. BioMed Central 2022-06-02 /pmc/articles/PMC9164838/ /pubmed/35655171 http://dx.doi.org/10.1186/s12876-022-02360-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kurokawa, Suguru Yoneda, Masato Ogawa, Yuji Honda, Yasushi Kessoku, Takaomi Imajo, Kento Saito, Satoru Nakajima, Atsushi Hotta, Kikuko Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma |
title | Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma |
title_full | Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma |
title_fullStr | Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma |
title_full_unstemmed | Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma |
title_short | Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma |
title_sort | two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164838/ https://www.ncbi.nlm.nih.gov/pubmed/35655171 http://dx.doi.org/10.1186/s12876-022-02360-4 |
work_keys_str_mv | AT kurokawasuguru twodifferentiallymethylatedregionnetworksinnonalcoholicfattyliverdiseaseviralhepatitisandhepatocellularcarcinoma AT yonedamasato twodifferentiallymethylatedregionnetworksinnonalcoholicfattyliverdiseaseviralhepatitisandhepatocellularcarcinoma AT ogawayuji twodifferentiallymethylatedregionnetworksinnonalcoholicfattyliverdiseaseviralhepatitisandhepatocellularcarcinoma AT hondayasushi twodifferentiallymethylatedregionnetworksinnonalcoholicfattyliverdiseaseviralhepatitisandhepatocellularcarcinoma AT kessokutakaomi twodifferentiallymethylatedregionnetworksinnonalcoholicfattyliverdiseaseviralhepatitisandhepatocellularcarcinoma AT imajokento twodifferentiallymethylatedregionnetworksinnonalcoholicfattyliverdiseaseviralhepatitisandhepatocellularcarcinoma AT saitosatoru twodifferentiallymethylatedregionnetworksinnonalcoholicfattyliverdiseaseviralhepatitisandhepatocellularcarcinoma AT nakajimaatsushi twodifferentiallymethylatedregionnetworksinnonalcoholicfattyliverdiseaseviralhepatitisandhepatocellularcarcinoma AT hottakikuko twodifferentiallymethylatedregionnetworksinnonalcoholicfattyliverdiseaseviralhepatitisandhepatocellularcarcinoma |